Compare NRXP & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | CLPR |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.2M | 59.1M |
| IPO Year | N/A | 2015 |
| Metric | NRXP | CLPR |
|---|---|---|
| Price | $1.86 | $3.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.67 | N/A |
| AVG Volume (30 Days) | ★ 520.3K | 56.2K |
| Earning Date | 01-01-0001 | 06-05-2026 |
| Dividend Yield | N/A | ★ 11.28% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,997,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $847.91 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.82 |
| 52 Week Low | $1.58 | $3.27 |
| 52 Week High | $3.84 | $4.69 |
| Indicator | NRXP | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 34.86 |
| Support Level | $1.65 | N/A |
| Resistance Level | $2.79 | $3.96 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 52.54 | 13.22 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.